Showing 121 - 140 results of 638 for search '"Prenatal testing"', query time: 0.19s Refine Results
  1. 121

    Case Report: Prenatal diagnosis of fetal tetrasomy 9p initially identified by non-invasive prenatal testing by Jialing Yu, Na Chen, Min Chen, Min Shen, Yeqing Qian, Minyue Dong, Minyue Dong, Minyue Dong

    Published 2022-10-01
    “…Herein, we report a fetus of tetrasomy 9p without obvious phenotypic manifestations during the first trimester that was identified by non-invasive prenatal testing (NIPT). NIPT revealed that the gain of 9p24.3–9p11 that was approximately 46.36 Mb in size. …”
    Get full text
    Article
  2. 122
  3. 123

    Factors associated with continuing emergence of β-thalassemia major despite prenatal testing: a cross-sectional survey by Al Sabbah H, Khan S, Hamadna A, Abu Ghazaleh L, Dudin A, Karmi BA

    Published 2017-09-01
    “…A questionnaire on prenatal testing, test results, pregnancy outcomes, and factors influencing the decision to terminate the pregnancy were used for this cross-sectional study. …”
    Get full text
    Article
  4. 124

    Prenatal testing - diagnostic possibilities in the 21st century with special emphasis on the diagnosis of genetic defects and heart defects by Grzegorz Tarsa, Rami Ben Rhaiem, Katarzyna Sudelska, Zuzanna Sawińska, Przemysław Kępka, Aleksandra Łokczewska-Bojar, Daria Kuziemkowska, Jan Kuźma, Magdalena Skotalczyk, Anna Łącka-Majcher

    Published 2023-09-01
    “…Invasive diagnostics include tests such as amniocentesis and chorionic villus biopsy. Prenatal tests provide information on the risk of genetic diseases such as trisomy 21, 13 and 18 chromosome. …”
    Get full text
    Article
  5. 125
  6. 126
  7. 127

    Performance capabilities of prenatal diagnosis of chromosomal anomalies: what changed with the introduction of non-invasive prenatal test (NIPT)? by O.A. Burka, V.S. Cherevashko, D.A. Martynova, G.I. Ishchenko, O.I. Maksian, S.O. Knyhnytska

    Published 2021-09-01
    “…This review systematizes scientific data on the possibilities and limitations of combined prenatal screening for detecting common chromosomal abnormalities (CA) in the first trimester of pregnancy, as well as an innovative technology – non-invasive prenatal test (NIPT) based on free fetal DNA fraction. …”
    Get full text
    Article
  8. 128
  9. 129
  10. 130

    The salience of genomic information to reproductive autonomy: Australian healthcare professionals’ views on a changing prenatal testing landscape by Kerryn Drysdale, J. L. Scully, L. Kint, K.-J. Laginha, J. Hodgson, I. Holmes, K. L. MacKay, A. J. Newson

    Published 2024-12-01
    “…Qualitative interviews with Australian healthcare professionals revealed that they value prenatal testing for its information-giving potential. …”
    Get full text
    Article
  11. 131
  12. 132
  13. 133

    Non-invasive prenatal testing (NIPT) by low coverage genomic sequencing: Detection limits of screened chromosomal microdeletions. by Marcel Kucharik, Andrej Gnip, Michaela Hyblova, Jaroslav Budis, Lucia Strieskova, Maria Harsanyova, Ondrej Pös, Zuzana Kubiritova, Jan Radvanszky, Gabriel Minarik, Tomas Szemes

    Published 2020-01-01
    “…To study the detection limits of chromosomal microaberrations in non-invasive prenatal testing with aim for five target microdeletion syndromes, including DiGeorge, Prader-Willi/Angelman, 1p36, Cri-Du-Chat, and Wolf-Hirschhorn syndromes. …”
    Get full text
    Article
  14. 134
  15. 135
  16. 136

    Evaluation of a decision aid for prenatal testing of fetal abnormalities: a cluster randomised trial [ISRCTN22532458] by Meiser Bettina, Metcalfe Sylvia, Lewis Sharon, Nagle Cate, Carlin John B, Bell Robin, Gunn Jane, Halliday Jane

    Published 2006-04-01
    “…Decision-making about prenatal testing for fetal abnormalities is often confusing and difficult for women and the effectiveness of decision aids in this field has not been established. …”
    Get full text
    Article
  17. 137

    An Optimized Method for Accurate Fetal Sex Prediction and Sex Chromosome Aneuploidy Detection in Non-Invasive Prenatal Testing. by Ting Wang, Quanze He, Haibo Li, Jie Ding, Ping Wen, Qin Zhang, Jingjing Xiang, Qiong Li, Liming Xuan, Lingyin Kong, Yan Mao, Yijun Zhu, Jingjing Shen, Bo Liang, Hong Li

    Published 2016-01-01
    “…Massively parallel sequencing (MPS) combined with bioinformatic analysis has been widely applied to detect fetal chromosomal aneuploidies such as trisomy 21, 18, 13 and sex chromosome aneuploidies (SCAs) by sequencing cell-free fetal DNA (cffDNA) from maternal plasma, so-called non-invasive prenatal testing (NIPT). However, many technical challenges, such as dependency on correct fetal sex prediction, large variations of chromosome Y measurement and high sensitivity to random reads mapping, may result in higher false negative rate (FNR) and false positive rate (FPR) in fetal sex prediction as well as in SCAs detection. …”
    Get full text
    Article
  18. 138
  19. 139
  20. 140